Amarin Corp Plc (AMRN)

[Pharmacydude]

Kiwi
The evidence is ABSOLUTELY ROBUST ENOUGH. Enough with your ridiculous BS about MITIGATE. I rarely put people on ignore but I’m tempted to with your absurd obsession that a respiratory infection trial is going to prove CVD reduction. Payers don’t want to pay (every country, every system) for a drug that doesn’t show results right away. Scotland denied V on the first round just like every single government payer. NICE and Spain rejected 3 times. It’s standard negotiating. They will likely deny again, trying to drive the price down.
Germany selected ezetimibe as it’s comparable therapy. As soon as that happened it was inevitable that Germany wouldn’t approve because they couldn’t legally offer more than the cost of generic ezetimibe ($30). The austerity act was an unexpected and uncontrollable event that killed Amarin’s automatic first year open launch. It was that simple. Nothing to do with KM or new Board/old Board. Nothing about “Saint Denner would have known the right people to bribe”.
All about $$$$$ and ABSOLUTELY NOTHING TO DUE WITH LACKING MITIGATE DATA ?????
PLEASE JUST STOP!!!!! ???? please!! You sound ridiculous and uninformed

This company has another year ahead with struggling income and restricting expenses that will keep this SP in the toilet. Ignore this stock, check back every week or 2 like I do, and enjoy the summer.
Nothing to see here